Cyclacel Pharma (CYCC) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Total other income (expense): 77K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Total other income (expense): 77K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($0.16), $0.04 worse than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
- ClearSign Technologies (CLIR) Tops Q2 EPS by 8c
- Futu Holdings Limited (FUTU) Tops Q2 EPS by 23c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
